Trial
NCT00838578
Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Kyowa Kirin Co., Ltd.
Collaborators
Kyowa Hakko Kirin Pharma, Inc.
Condition
Colorectal Cancer
Intervention
KRN330
Why stopped
Per protocol, the study was terminated based on interim analysis results
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-26